44 studies found for:    " January 23, 2013":" February 22, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Pharmacokinetics of Tenofovir and Tenofovir-diphosphate, Emtricitabine and Emtricitabine-triphosphate, and Rilpivirine Once Daily Over 14 Days Following Drug Intake Cessation in Healthy Volunteers
Condition: HIV
Intervention: Drug: Eviplera®
22 Recruiting Carolina Alcohol and Drug Resources
Condition: HIV
Intervention: Behavioral: Comprehensive substance abuse services
23 Active, not recruiting Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy
Condition: HIV
Intervention: Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF‐T), given via intravenous infusion.
24 Completed The Effect of Antacids and Multivitamins on Raltegravir
Condition: HIV
Interventions: Dietary Supplement: Multivitamins;   Dietary Supplement: Sodium bicarbonate;   Drug: Maalox Plus extra;   Drug: Raltegravir 400 mg
25 Unknown  Mater-Bronx Rapid HIV Testing Project.
Condition: Human Immunodeficiency Virus
Interventions: Other: No participant choice of counselor;   Other: Participant choice of counselor
26 Completed A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services
Condition: HIV Prevention
Intervention: Drug: emtricitabine 200mg/tenofovir 300mg
27 Completed The Multimedia HIV/STI Prevention for Drug-Involved Female Offenders
Conditions: HIV;   Sexually Transmitted Infections
Interventions: Behavioral: Multimedia WORTH;   Behavioral: Traditional WORTH;   Behavioral: Wellness Promotion
28 Recruiting Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico
Conditions: HIV;   AIDS;   Substance Abuse
Interventions: Behavioral: Enhanced HIV Care Access and Retention Intervention;   Behavioral: HIV Testing Campaign;   Behavioral: Treatment Re-engagement Campaign;   Behavioral: Patient Navigator Linkage to Care and Substance Abuse Treatment Team;   Behavioral: Mobile Care Clinic
29 Unknown  Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults
Conditions: Influenza;   HIV;   Tuberculosis
Intervention: Biological: Trivalent Inactivated Influenza Vaccine
30 Completed A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy
Conditions: HIV;   Contraception
Interventions: Drug: Levonorgestrel;   Drug: Nevirapine;   Drug: Efavirenz
31 Completed Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
Conditions: HIV;   Hypercholesterolaemia
Interventions: Drug: raltegravir;   Drug: Atorvastatin
32 Completed TDF Long Term Study
Condition: HIV-infected Thai Children
Intervention: Drug: tenofovir (TDF)
33 Unknown  Clinic-based ART Diagnostic Evaluation
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infection;   RNA Virus Infections;   Virus Diseases
Intervention: Other: HIV-1 viral load testing
34 Completed Second-line Therapy
Condition: Treatment Failure of Second-line ART in Asian HIV-infected Children
Intervention:
35 Completed
Has Results
Adherence Support Intervention for Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in Estonia
Conditions: HIV;   AIDS;   Medication Adherence
Intervention: Behavioral: Situated Optimal Adherence Intervention
36 Completed
Has Results
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
Conditions: Chronic Hepatitis C;   Human Immunodeficiency Virus
Interventions: Drug: Sofosbuvir;   Drug: RBV
37 Completed Safety Study of the PrePex Device for Non-Surgical Adult Male Circumcision During Phased in National Implementation in an Effort to Prevent the Spread of HIV
Condition: Male Circumcision
Intervention: Device: PrePex™ device
38 Completed
Has Results
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
Conditions: HIV;   Hepatitis B;   Hepatitis C;   Carcinoma, Hepatocellular;   AIDS
Interventions: Other: ELISA;   Other: Rapid Test
39 Active, not recruiting Evaluation on Seropositive Patients of a Synthetic Vaccine Targeting the HIV Tat Protein
Condition: AIDS
Intervention: Biological: Tat Oyi
40 Suspended Egrifta Replacement and Sleep Disordered Breathing
Condition: Lipodystrophy
Intervention: Drug: Tesamorelin (Egrifta)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-44) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.